← Leaderboards
Desikan Rajagopal
Invasc Therapeutics, Inc.
$390,635
Attributed
$390,635
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$390,635 · 2
By mechanism
R43$390,635 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoPropertyEnzymesIn Vitro ModelModificationPharmaceutical PreparationsCellsDrug CandidateHeartIn VitroAortaIn Vivo ModelAnimalsNitric OxideAffectCardiovascular DiseasesBaseDesignAmericanGenerationsAntioxidantsInflammatoryBlood VesselsPublic Health Relevance